Day: April 14, 2023

Regulated Information Leuven, BELGIUM, Boston, MA, US – April 14, 2023 – 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on April 12, 2023 from Atlas Special Opportunities LLC indicating that as of April 11, 2023, it held 26,728,439 shares of the then outstanding 632,659,186 shares, and therefore crossed above the threshold (3%) by virtue of acquisition of voting securities. See Annex 1 About Oxurion Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic...

                                                         NEOLIFE Forte croissance au premier trimestre 2023 NEOLIFE® (Euronext Growth : FR0011636083 – ALNLF), acteur majeur des éco-matériaux issus des technologies vertes et reconnu pour son innovation en solutions constructives durables (la « Société »), annonce une forte croissance. Les différentes actions et la restructuration du groupe NEOLIFE réalisées en 2022 permettent d’annoncer sur le 1er trimestre 2023 :Un chiffre d’affaires de 4 M€ au titre du premier trimestre 2023, soit 17% de croissance par rapport au premier trimestre 2022Une marge brute qui progresse de 40% par rapport au premier trimestre 2022 et un taux de marge brute qui s’améliore de 5 pointsFournisseur de chantiers des JO 2024Chiffre d’affaires par métier*(données en M€) Q12023 Q12022 VariationMatériaux...

ISS, an independent, third-party proxy advisory firm, recommends Sernova’s shareholders vote FOR all management’s director nominees using ONLY management’s WHITE proxy. ISS notes the dissidents failed to present a detailed explanation of their case and there does not seem to be a compelling case that change at Sernova is warranted at this time. Shareholders who have questions or need assistance with voting their shares should contact Sernova Corp.’s strategic advisor and proxy solicitation agent Laurel Hill Advisory Group by telephone at 1-877-452-7184 or by email at assistance@laurelhill.com.LONDON, Ontario, April 14, 2023 (GLOBE NEWSWIRE) — Sernova Corp. (“Sernova” or the “Corporation”) (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a clinical-stage company and leader in cell therapeutics, is pleased to announce that Institutional...

Bermuda, 14 April 2023 –  Avance Gas Holding Ltd (OSE: AGAS) announces that the annual report for the financial year ended 31 December 2022 is published today. The report is attached in European Single Electronic Format (ESEF) and as a PDF file which is also available on the Company’s website www.avancegas.com. Avance Gas Holding Limited has also published the ESG Report for 2022. Both reports are attached as a PDF and are also available on the Company’s website. About Avance Gas:Avance Gas operates in the global market for transportation of liquefied petroleum gas (LPG). The Company is one of the world’s leading owners and operators of very large gas carrier (VLGC) and operates a fleet of thirteen ships and three Dual Fuel LPG newbuildings due for delivery in 2024. For more information about Avance Gas, please...

TELUS recognized for consistent network quality, video experience and speed, taking home eleven Fixed Broadband Experience top spots across B.C. and Alberta from Opensignal TELUS PureFibre leading home Internet experience in B.C. and Alberta TORONTO, April 14, 2023 (GLOBE NEWSWIRE) — Today, TELUS is proud to announce its industry-leading results from Opensignal’s April 2023 Canada Fixed Broadband Experience Report, bringing home top honours in Canada’s two westernmost provinces. TELUS received outright wins for Consistent Quality, Video Experience and Upload Speed in B.C. and Alberta, as well as took first place in B.C. for Broadband Success Rate. It also tied for first in B.C. and Alberta for Peak Download Speed, and tied for first in Alberta for Broadband Success Rate. These results demonstrate TELUS’ network dominance in Fixed...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 14, 2023 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the publication of an abstract for a poster presentation of early clinical data on the bispecific antibody petosemtamab in advanced gastric/esophageal adenocarcinoma (GEA) at the American Association for Cancer Research (AACR) Annual Meeting 2023 taking place in Orlando, Florida April 14-19, 2023. Petosemtamab, or MCLA-158, is a human IgG1 Biclonics® designed to bind to cancer cells expressing epidermal growth factor receptor (EGFR) and leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5). Petosemtamab is in clinical development in the expansion...

– Robust 36% overall response rate (ORR) in 42 evaluable patients – 6 months median duration of response with 17 patients still on treatment as of Nov. 28, 2022 data cutoff – End-of-Phase meeting with U.S. Food & Drug Administration provides clarity to potential registration path in HNSCC – Investor call on April 17, 2023 at 6:30 p.m. ET ET UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 14, 2023 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the publication of an abstract for a plenary session oral presentation of interim clinical data on the bispecific antibody petosemtamab in previously treated head and neck squamous cell...